Citations

Clear

431 citation(s) found for "Schmidt, T".

A Rare Cause of Prevascular (Anterior) Mediastinal Mass
Schmidt, Walker, Hla, Diana, Araoz, Philip, Olson, Eric J., Pennington, Kelly M., Schmidt, Walker M. , Schmidt, Walker, Hla, Diana A. , Araoz, Philip, Olson, Eric J., Pennington, Kelly M.

Mayo Clinic

Annals of the American Thoracic Society | April 29, 2022 | Volume: 19 | Issue: 5 | Pages: 850-853

10.1513/annalsats.202109-1015cc | PMID 35486082 Get It

Risk factors for local atypical fibroxanthoma recurrence and progression to pleomorphic dermal sarcoma: A meta‐analysis of individualized participant data
Ørholt, Mathias , Aaberg, Frederik L., Abebe, Kiya , Roenigk, Randall K., Venzo, Alessandro, Schmidt, Grethe , Klyver, Helle, Jensen, David Hebbelstrup , Herly, Mikkel , Vester‐Glowinski, Peter, Walsh, S.

Mayo Clinic

Journal of Surgical Oncology | April 20, 2022 | Volume: 126 | Issue: 3 | Pages: 555-562

10.1002/jso.26898 | PMID 35441377 Get It

AbstractBackgroundRisk factors for local atypical fibroxanthoma (AFX) recurrence and progression to pleomorphic dermal sarcoma (PDS) have not previously been identified.ObjectiveTo identify risk factors and provide follow‐up suggestions for local AFX recurrence and progression to PDS.Methods and MaterialsA literature search was performed in the PubMed, EMBASE, and Cochrane databases. The PRISMA and MOOSE guidelines were followed. The risks of local AFX recurrence and progression to PDS were presented as Kaplan–Meier plots and risk factors were presented as hazard ratios (HRs) calculated with univariate and multivariate Cox regression.ResultsFive hundred and ninety‐eight patients with AFX from 14 studies were included. Age >74 years and male sex significantly increased the risk of local recurrence (HR: 7.31 [95% confidence interval [CI]: 1.78–30.0], p < 0.01 and HR: 2.89 [95% CI: 1.04–8.01], p < 0.05, respectively). There was no difference when comparing wide local excision and Mohs' micrographic surgery (p = 0.89). The risks of local AFX recurrence and progression to PDS after 2 years were <1%.ConclusionA more intensive follow‐up regimen could be considered in patients >74 years old and males due to the higher risk of local AFX recurrence.
Gerrymandering and Political Determinants of Health
Syed, Quratulain , Schmidt, Stacie , Powell, Rhea E. , Connolly, Nancy C. , Cowart, Jennifer B. , Newby, Celeste, Syed, Quratulain , Henry, Tracey L. , Connolly, Nancy

Mayo Clinic

Population Health Management | April 15, 2022 | Volume: 25 | Issue: 4 | Pages: 568-570

10.1089/pop.2021.0362 | PMID 35426738 Get It

Four decades of experience of prosthetic valve endocarditis reflect a high variety of diverse pathogens
Oberbach, Andreas , Schlichting, Nadine , Hagl, Christian, Lehmann, Stefanie, Kullnick, Yvonne, Friedrich, Maik , Köhl, Ulrike, Horn, Friedemann, Kumbhari, Vivek , Löffler, Bettina , Jóskowiak, Dominik , Born, F. , Saha, Shekhar , Bagaev, Erik, Joskowiak, Dominik , Saha, Shekhar , Koehl, Ulrike , Schmidt, Frank

Mayo Clinic

Cardiovascular Research | April 14, 2022 | Volume: 119 | Issue: 2 | Pages: 410-428

10.1093/cvr/cvac055 | PMID 35420122 Get It

AbstractProsthetic valve endocarditis (PVE) remains a serious condition with a high mortality rate. Precise identification of the PVE-associated pathogen/s and their virulence is essential for successful therapy and patient survival. The commonly described PVE-associated pathogens are staphylococci, streptococci, and enterococci, with Staphylococcus aureus being the most frequently diagnosed species. Furthermore, multi-drug resistance pathogens are increasing in prevalence and continue to pose new challenges mandating a personalized approach. Blood cultures in combination with echocardiography are the most common methods to diagnose PVE, often being the only indication, it exists. In many cases, the diagnostic strategy recommended in the clinical guidelines does not identify the precise microbial agent, and frequently, false-negative blood cultures are reported. Despite the fact that blood culture findings are not always a good indicator of the actual PVE agent in the valve tissue, only a minority of re-operated prostheses are subjected to microbiological diagnostic evaluation. In this review, we focus on the diversity and the complete spectrum of PVE-associated bacterial, fungal, and viral pathogens in blood and prosthetic heart valve, their possible virulence potential, and their challenges in making a microbial diagnosis. We are curious to understand if the unacceptable high mortality of PVE is associated with the high number of negative microbial findings in connection with a possible PVE. Herein, we discuss the possibilities and limits of the diagnostic methods conventionally used and make recommendations for enhanced pathogen identification. We also show possible virulence factors of the most common PVE-associated pathogens and their clinical effects. Based on blood culture, molecular biological diagnostics, and specific valve examination, better derivations for the antibiotic therapy as well as possible preventive intervention can be established in the future.
A transcriptomics-guided drug target discovery strategy identifies receptor ligands for lung regeneration
Wu, Xinhui , Bos, I. Sophie T., Conlon, Thomas M. , Ansari, Meshal , Verschut, Vicky, Koog, Luke van der , Verkleij, Lars A., D’Ambrosi, Angela, Matveyenko, Aleksey V. , Schiller, Herbert B. , Königshoff, Mélanie , Schmidt, Martina , Kistemaker, Loes , van der Koog, Luke , Matveyenko, Aleksey V , Yildirim, Ali Önder , Gosens, Reinoud , Gosens, Reinoud

Mayo Clinic

Science Advances | March 23, 2022 | Volume: 8 | Issue: 12 | Pages: No page available

10.1126/sciadv.abj9949 | PMID 35319981 Get It

Currently, there is no pharmacological treatment targeting defective tissue repair in chronic disease. Here, we used a transcriptomics-guided drug target discovery strategy using gene signatures of smoking-associated chronic obstructive pulmonary disease (COPD) and from mice chronically exposed to cigarette smoke, identifying druggable targets expressed in alveolar epithelial progenitors, of which we screened the function in lung organoids. We found several drug targets with regenerative potential, of which EP and IP prostanoid receptor ligands had the most profound therapeutic potential in restoring cigarette smoke–induced defects in alveolar epithelial progenitors in vitro and in vivo. Mechanistically, we found, using single-cell RNA sequencing analysis, that circadian clock and cell cycle/apoptosis signaling pathways were differentially expressed in alveolar epithelial progenitor cells in patients with COPD and in a relevant model of COPD, which was prevented by prostaglandin E2 or prostacyclin mimetics. We conclude that specific targeting of EP and IP receptors offers therapeutic potential for injury to repair in COPD.
Abstract 181: Meta-Analysis of Genome-Wide Association Studies Identifies Two New Susceptibility Loci for Intracerebral Hemorrhage
Woo, Daniel , Falcone, Guido J. , Devan, William J., Brown, W. Mark , Biffi, Alessandro , Deka, Ranjan , Jagiełła, Jeremiasz , Jiménez‐Conde, Jordi , Urbanik, Andrzej, Tirschwell, David L, Silliman, Scott, Worrall, Bradford B. , Kidwell, Chelsea S., Greenberg, Steven M. , Rothwell, Peter M. , Słowik, Agnieszka , Schmidt, Reinhold, Langefeld, Carl D. , Anderson, Christopher D. , Woo, Jessica Graus , Martin, Lisa Joy , Norrving, Bo , Tirschwell, David L, Selim, Magdy H. , Meschia, James F. , Montaner, Joan , Fernández‐Cadenas, Israel , Dichgans, Martin , Lindgren, Arne G. , Rosand, Jonathan M.

Mayo Clinic

Stroke | March 20, 2022 | Volume: 45 | Issue: suppl_1 | Pages: No page available

10.1161/str.45.suppl_1.181 Get It

Background: Intracerebral hemorrhage (ICH) is the stroke subtype with the worst prognosis and has no established acute treatment. ICH is classified as lobar and non-lobar based on the location of the hemorrhage, with genetic variation contributing to risk of both subtypes. We report the first genome wide association study (GWAS) of this condition. Methods: The discovery phase included GWAS data (Illumina 610 or Affymetrix 6.0) from 6 ICH studies that enrolled subjects of European ancestry in the US and Europe. Cases were classified as lobar or non-lobar ICH based on head CT. ICH-free controls were selected from ambulatory clinics or by random digit dialing. Standard quality controls filters were applied and principal component analysis was used to account for population structure. Unobserved genotypes were inferred by imputation to 1000 genomes references panels. Association testing was carried out using logistic regression, assuming additive effects, and including age, gender and principal components in the model. Meta-analyses were completed using the inverse normal method, weighting by sample size. Replication of signals with p<1x10E-6 was pursued in an independent multi-ethnic study utilizing direct genotyping. Results: The discovery phase included 1545 cases (664 lobar and 881 non-lobar) and 1481 controls, and tested 5,358,103 SNPs. Two loci were identified: for lobar ICH, an intergenic region located on chromosome 12q21.1 (rs11179580: minor allele frequency [MAF] 0.22, OR 1.54, 95% CI 1.33 - 1.84; p = 6.7x10E-8); and for non-lobar ICH, a region on chromosome 1q22 encompassing the PMF1 and SLC25A44 genes (rs2984613: MAF 0.31, OR 1.45, 95% CI 1.2 - 1.64; p = 8.9x10E-9). Replication included 1256 cases (329 whites, 506 blacks and 421 Hispanics) and 760 controls (237 whites, 346 blacks and 177 Hispanics) and confirmed both loci: 12q21.1 (p = 0.037, meta-analysis p = 2.3x10E-8) and 1q22 (p = 3.0x10E-4, meta-analysis p = 2.2x10E-11). Conclusions: Two new susceptibility loci for ICH were identified, both showing location-specificity. These results confirm the presence of biological heterogeneity across ICH subtypes and highlight that different genetic risk factors may contribute to the small vessel diseases that underlie each ICH subtype.
Enhancer retargeting of CDX2 and UBTF::ATXN7L3 define a subtype of high-risk B-progenitor acute lymphoblastic leukemia
Kimura, Shunsuke , Montefiori, Lindsey E. , Zhao, Yaqi , Gao, Qingsong , Paietta, Elisabeth , Mead, Paul E., Gu, Zhaohui , Litzow, Mark R. , Rowe, Jacob M. , Luger, Selina M. , Schmidt, Breon , Ekert, Paul G. , Oshlack, Alicia , Grimmond, Sean M. , Rehn, Jacqueline , Breen, James , Meggendorfer, Manja , Walter, Wencke , Kern, Wolfgang , Haferlach, Torsten , Brady, Samuel W. , Zhang, Jinghui , Blombery, Piers , Montefiori, Lindsey , Zhao, Yaqi , Gao, Qingsong , Gu, Zhaohui , Litzow, Mark R. , Hunger, Stephen P , Ryland, Georgina L , Oshlack, Alicia , Grimmond, Sean M , Rehn, Jacqueline , Yeung, David , White, Deborah L , Pui, Ching-Hon , Walter, Wencke , Roberts, Kathryn G , Mullighan, Charles G , Kimura, Shunsuke , Kern, Wolfgang , Iacobucci, Ilaria , Haferlach, Claudia , Laird, Alexander , Stock, Wendy , Hunger, Stephen P. , Aldoss, Ibrahim , Jabbour, Elias , Roberts, Kathryn G. , Mullighan, Charles G.

Mayo Clinic

Blood | February 22, 2022 | Volume: 139 | Issue: 24 | Pages: 3519-3531

10.1182/blood.2022015444 | PMID 35192684 Get It

Abstract Transcriptome sequencing has identified multiple subtypes of B-progenitor acute lymphoblastic leukemia (B-ALL) of prognostic significance, but a minority of cases lack a known genetic driver. Here, we used integrated whole-genome (WGS) and -transcriptome sequencing (RNA-seq), enhancer mapping, and chromatin topology analysis to identify previously unrecognized genomic drivers in B-ALL. Newly diagnosed (n = 3221) and relapsed (n = 177) B-ALL cases with tumor RNA-seq were studied. WGS was performed to detect mutations, structural variants, and copy number alterations. Integrated analysis of histone 3 lysine 27 acetylation and chromatin looping was performed using HiChIP. We identified a subset of 17 newly diagnosed and 5 relapsed B-ALL cases with a distinct gene expression profile and 2 universal and unique genomic alterations resulting from aberrant recombination-activating gene activation: a focal deletion downstream of PAN3 at 13q12.2 resulting in CDX2 deregulation by the PAN3 enhancer and a focal deletion of exons 18-21 of UBTF at 17q21.31 resulting in a chimeric fusion, UBTF::ATXN7L3. A subset of cases also had rearrangement and increased expression of the PAX5 gene, which is otherwise uncommon in B-ALL. Patients were more commonly female and young adult with median age 35 (range,12-70 years). The immunophenotype was characterized by CD10 negativity and immunoglobulin M positivity. Among 16 patients with known clinical response, 9 (56.3%) had high-risk features including relapse (n = 4) or minimal residual disease &gt;1% at the end of remission induction (n = 5). CDX2-deregulated, UBTF::ATXN7L3 rearranged (CDX2/UBTF) B-ALL is a high-risk subtype of leukemia in young adults for which novel therapeutic approaches are required.
Prospective validation of a new imaging scorecard to assess leptomeningeal metastasis: A joint EORTC BTG and RANO effort
Rhun, Émilie Le , Devos, Patrick , Winklhofer, Sebastian , Lmalem, Hafida, Brandsma, Dieta , Kumthekar, Priya , Castellano, Antonella , Compter, Annette , Dhermain, F., Franceschi, Enrico , Gempt, Jens , Hattingen, Elke , Hempel, Johann, Lukacova, Slávka , Minniti, Giuseppe , O’Brien, Barbara , Postma, Tjeerd J., Roth, Patrick , Schaefer, Niklaus , Thust, Steffi, Bent, Martin J. van den , Hoorn, Anouk van der , Vogin, Guillaume , Smits, Marion , Jaeckle, Kurt A. , Preusser, Matthias , Glantz, Michael , Wen, Patrick Y. , Weller, Michael , Le Rhun, Emilie , Gállego Pérez-Larraya, Jaime , Snijders, Tom J , Smits, Marion , Jaeckle, Kurt A , Preusser, Matthias , Weller, Michael , van den Bent, Martin J , Franceschi, Enrico , Roth, Patrick , Forsyth, Peter A , Furtner, Julia , Galldiks, Norbert , Rudà, Roberta , Schmidt, Nils Ole , Thust, Stefanie Catherine , Tonn, Joerg-Christian , Wen, Patrick Yung , Bendszus, Martin , Minniti, Giuseppe

Mayo Clinic

Neuro-Oncology | February 11, 2022 | Volume: 24 | Issue: 10 | Pages: 1726-1735

10.1093/neuonc/noac043 | PMID 35157772 Get It

Abstract Background Validation of the 2016 RANO MRI scorecard for leptomeningeal metastasis failed for multiple reasons. Accordingly, this joint EORTC Brain Tumor Group and RANO effort sought to prospectively validate a revised MRI scorecard for response assessment in leptomeningeal metastasis. Methods Coded paired cerebrospinal MRI of 20 patients with leptomeningeal metastases from solid cancers at baseline and follow-up after treatment and instructions for assessment were provided via the EORTC imaging platform. The Kappa coefficient was used to evaluate the interobserver pairwise agreement. Results Thirty-five raters participated, including 9 neuroradiologists, 17 neurologists, 4 radiation oncologists, 3 neurosurgeons, and 2 medical oncologists. Among single leptomeningeal metastases-related imaging findings at baseline, the best median concordance was noted for hydrocephalus (Kappa = 0.63), and the worst median concordance for spinal linear enhancing disease (Kappa = 0.46). The median concordance of raters for the overall response assessment was moderate (Kappa = 0.44). Notably, the interobserver agreement for the presence of parenchymal brain metastases at baseline was fair (Kappa = 0.29) and virtually absent for their response to treatment. 394 of 700 ratings (20 patients x 35 raters, 56%) were fully completed. In 308 of 394 fully completed ratings (78%), the overall response assessment perfectly matched the summary interpretation of the single ratings as proposed in the scorecard instructions. Conclusion This study confirms the principle utility of the new scorecard, but also indicates the need for training of MRI assessment with a dedicated reviewer panel in clinical trials. Electronic case report forms with “blocking options” may be required to enforce completeness and quality of scoring.
Abstract 154: Sex-specific Genome Wide Association Study Of Early-onset Ischemic Stroke
Leeuw, Frank‐Erik de , Cadenas, Israel Fernández, Słowik, Agnieszka, Conde, Jordi Jiménez, Schmidt, Reinhold, Sharma, Pankaj , Rothwell, Peter M. , Sudlow, Catherine, Debette, Stéphanie , Markus, Hugh S. , Saleheen, Danish , Danesh, John , Zand, Ramin , Worrall, Bradford B. , Woo, Daniel , Lee, Jin-moo, Irvin, Marguerite R. , Rosand, Jonathan, Kamatani, Yoichiro, Xu, Huichun , Kittner, Steven J. , Debette, Stephanie , Zand, Ramin , Tomppo, Liisa , Rannikmäe, Kristiina , Stanne, Tara M. , Putaala, Jukka , Strbian, Daniel , Jern, Christina , Boncoraglio, Giorgio B. , Lindgren, Arne G. , Lemmens, Robin , Melander, Olle , Levi, Christopher , Sudlow, Catherine, Metso, Tiina M. , Paré, Guillaume , Meschia, James F. , Rundek, Tatjana , Lee, Jin‐Moo , McDonough, Caitrin W. , Rexrode, Kathryn M. , Wassertheil-Smoller, Sylvia W , Rosand, Jonathan M. , Gieger, Christian , Müller‐Nurasyid, Martina , Salomaa, Veikko , Kamatani, Yoichiro, Walters, Robin G. , Chen, Zhengming , Dichgans, Martin , Malik, Rainer , Gaynor, Brady J. , Cole, John W. , Mitchell, Braxton D.

Mayo Clinic

Stroke | February 3, 2022 | Volume: 53 | Issue: Suppl_1 | Pages: No page available

10.1161/str.53.suppl_1.154 Get It

Introduction: Genetic studies of early-onset disease have been an effective strategy to identify novel pathways and drug targets generalizable also to later-onset disease. Few studies have investigated the sex-specific genetic associations with early-onset ischemic stroke even though several features of ischemic stroke differ between males and females. We hypothesized that stratifying the GWAS by sex would reveal novel stroke loci. Methods: We performed a transethnic ischemic stroke GWAS of 3,056 female cases and 4,462 male cases < 60 years-old and 16,192 and 16,048 sex-matched controls, respectively, from the Early Onset Stroke Genetics Consortium. Results: We identified a significant association in women with a locus in close proximity to TMX1 , a transmembrane platelet protein that inhibits platelet function. Additionally, we identified 2 other suggestive (P < 5 x 10 -6 ) loci in females (see Table), i.e., at APOH , which encodes beta2-glycoprotein I, an established GWAS locus for lipoprotein(a), and LRFN2 which has been previously reported to associate with obesity-related measures and type II diabetes. We observed suggestive evidence for association in males with MMP3/MMP12 , a known stroke susceptibility locus. Conclusions: Despite a very modest sample size, sex-specific analyses identified suggestive associations at biologically important novel loci in females and a known stroke locus in males. Further studies of sex-specific associations in both early- and later-onset ischemic stroke are needed.
Sex-specific lesion pattern of functional outcomes after stroke
Bretzner, Martin , Hong, Sung‐Min , Schirmer, Markus D. , Cohen, Alexander L. , Regenhardt, Robert W. , Donahue, Kathleen, Nardin, Marco, Etherton, Mark R. , Hancock, Brandon L., Mocking, Steven J. T. , McIntosh, Elissa C. , Benavente, Oscar, Donatti, Amanda , Heitsch, Laura , Jiménez-Conde, Jordi , Kittner, Steven J. , Levi, Christopher , Rolfs, Arndt , Schmidt, Reinhold , Sharma, Pankaj , Słowik, Agnieszka , Söderholm, Martin , Sousa, Alessandro , Stanne, Tara M. , Strbian, Daniel , Thijs, Vincent , Wassélius, Johan , Woo, Daniel , Zand, Ramin , McArdle, Patrick F. , Worrall, Bradford B. , Maguire, Jane , Fox, Michael , Bzdok, Danilo , Wu, Ona , Rost, Natalia S. , Bretzner, Martin , Cohen, Alexander , Etherton, Mark R , Jood, Katarina , Lemmens, Robin , Strbian, Daniel , Regenhardt, Robert W , Wu, Ona , Zand, Ramin , Bonkhoff, Anna K. , Dalca, Adrian Vasile , Giese, Anne‐Katrin , Attia, John , Bevan, Steve , Cole, John W. , Griessenauer, Christoph J. , Holmegaard, Lukas , Lemmens, Robin , McDonough, Caitrin W. , Meschia, James F. , Phuah, Chia‐Ling , Ropele, Stefan , Rosand, Jonathan M. , Roquer, Jaume , Rundek, Tatjana , Sacco, Ralph L. , Tatlisumak, Turgut , Vagal, Achala , Jern, Christina , Lindgren, Arne G.

Mayo Clinic

Brain Communications | January 31, 2022 | Volume: 4 | Issue: 2 | Pages: No page available

10.1093/braincomms/fcac020 | PMID 35282166 Get It

Abstract Stroke represents a considerable burden of disease for both men and women. However, a growing body of literature suggests clinically relevant sex differences in the underlying causes, presentations and outcomes of acute ischaemic stroke. In a recent study, we reported sex divergences in lesion topographies: specific to women, acute stroke severity was linked to lesions in the left-hemispheric posterior circulation. We here determined whether these sex-specific brain manifestations also affect long-term outcomes. We relied on 822 acute ischaemic patients [age: 64.7 (15.0) years, 39% women] originating from the multi-centre MRI-GENIE study to model unfavourable outcomes (modified Rankin Scale &gt;2) based on acute neuroimaging data in a Bayesian hierarchical framework. Lesions encompassing bilateral subcortical nuclei and left-lateralized regions in proximity to the insula explained outcomes across men and women (area under the curve = 0.81). A pattern of left-hemispheric posterior circulation brain regions, combining left hippocampus, precuneus, fusiform and lingual gyrus, occipital pole and latero-occipital cortex, showed a substantially higher relevance in explaining functional outcomes in women compared to men [mean difference of Bayesian posterior distributions (men – women) = −0.295 (90% highest posterior density interval = −0.556 to −0.068)]. Once validated in prospective studies, our findings may motivate a sex-specific approach to clinical stroke management and hold the promise of enhancing outcomes on a population level.